Norway - Potential Years of Life Lost from Prostate Malignant Neoplasms
Since 2014, Norway Potential Years of Life Lost from Prostate Malignant Neoplasms decreased by 3.7% year on year. In 2019, the country was ranked number 22 comparing other countries in Potential Years of Life Lost from Prostate Malignant Neoplasms at 45 Years Per Hundred Thousand Men Aged 0-69. Norway is overtaken by United States, which was ranked number 21 with 45.7 Years Per Hundred Thousand Men Aged 0-69 and is followed by Austria with 44.1 Years Per Hundred Thousand Men Aged 0-69. Latvia topped the ranking with 119.4 Years Per Hundred Thousand Men Aged 0-69 in 2019, that is a growth of 0.2% versus 2018. South Africa, Estonia and Lithuania respectively ranked number 2, 3 and 4 in this ranking. Luxembourg witnessed the best average annual growth at +16.7% per year, while Iceland witnessed the worst performance at -7.5% per year.
Loading...
Date | Years Per Hundred Thousand Men Aged 0-69 |
---|---|
2019 | 45.00 |
2018 | 47.00 |
2017 | 49.10 |
2016 | 51.60 |
2015 | 52.30 |
How does Norway rank in Potential Years of Life Lost from Prostate Malignant Neoplasms?
# | 39 Countries | Years Per Hundred Thousand Men Aged 0-69 | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Latvia
|
119.40 | 2019 | +0.2 % | -2.7 % | View data | |
2 |
#2
South Africa
|
108.20 | 2019 | +0.7 % | +1.4 % | View data | |
21 |
#21
United States
|
45.70 | 2019 | -1.3 % | -1.0 % | View data | |
22 |
#22
Norway
|
45.00 | 2019 | -4.3 % | -3.7 % | View data | |
23 |
#23
Austria
|
44.10 | 2019 | -1.6 % | -1.6 % | View data |